80
Participants
Start Date
December 31, 2005
Primary Completion Date
March 31, 2014
Study Completion Date
May 31, 2015
fenretinide lipid matrix
ketoconazole
laboratory biomarker analysis
pharmacological study
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus, Atlanta
University of Chicago Comer Children's Hospital, Chicago
Cook Children's Medical Center - Fort Worth, Fort Worth
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto
Children's Hospital and Regional Medical Center - Seattle, Seattle
Childrens Hospital Los Angeles, Los Angeles
Children's Hospital Boston, Boston
C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor
Cincinnati Children's Hospital Medical Center, Cincinnati
Children's Hospital of Philadelphia, Philadelphia
National Cancer Institute (NCI)
NIH
Children's Hospital Los Angeles
OTHER